Outlook Therapeutics, Inc. (OTLK) › Shares OutstandingOutlook Therapeutics, Inc. (OTLK) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2015: 9.44M2016: 22.80M2017: 24.93M2018: 9.03M2019: 28.61M2020: 127.18M2021: 176.46M2022: 227.31M2023: 13.01M2024: 23.91M2025: 53.89M53.89M2015Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202553.89M+125.4%202423.91M+83.7%202313.01M-94.3%2022227.31M+28.8%2021176.46M+38.7%2020127.18M+344.5%201928.61M+216.9%20189.03M-63.8%201724.93M+9.3%201622.80M+141.6%20159.44M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share